Couchbase (BASE) Insider Plans 1,321-Share Sale Under Rule 144
Rhea-AI Filing Summary
Couchbase, Inc. (NASDAQ: BASE) – Form 144 filing
The notice reports a planned Rule 144 sale of 1,321 common shares (aggregate market value $25,006.53) through Morgan Stanley Smith Barney, with an anticipated trade date of 20 June 2025 on the NASDAQ. The shares were originally received as restricted stock units on 15 June 2023. With 54,084,446 shares outstanding, the proposed sale represents roughly 0.002% of total shares, indicating minimal dilution.
The same shareholder has disposed of 3,316 shares during the past three months—1,016 shares on 16 June 2025 for $19,340.27 and 2,300 shares on 4 June 2025 under a 10b5-1 plan for $44,850.00—bringing total recent sales to 4,637 shares.
The filer affirms no knowledge of undisclosed adverse information, as required under Rule 144, and cites compliance with 10b5-1 where relevant.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale (0.002% float); signals limited impact on BASE’s capital structure or trading dynamics.
The Form 144 details a prospective disposal of just 1,321 shares, worth roughly $25k. Given the 54.1 million shares outstanding, the transaction is immaterial from a dilution or liquidity standpoint. Recent prior sales total 3,316 shares, suggesting the seller is following a steady liquidation pattern, partly under a 10b5-1 plan. Rule 144’s disclosure and the attestation of no undisclosed adverse information reduce governance risk. Overall, the filing is a routine administrative item with negligible financial impact.